Investors Press Release/News Aucta Receives its First Product Approval and Launches Vigabatrin for Oral Solution Under the Brand Name Vigadrone™ Aucta Pharmaceuticals and Oakrum Pharma Announce Product Development and Commercialization Partnership Aucta Pharmaceuticals Announces Licensing of Lamotrigine New Drug Application Aucta Pharmaceuticals AnnouncesLicensing of Vigabatrin for Oral Solution in China Aucta Pharma and Oakrum Pharma Announce Launch of Generic Version of JADENU(R) Sprinkle (Deferasirox Granules)
